Market Overview

Bank of America Merrill Lynch Reiterates Buy Rating, $40 PT on HCA Holdings

Related HCA
Top 4 NYSE Stocks In The Hospitals Industry With The Highest Revenue
Top 4 NYSE Stocks In The Hospitals Industry With The Lowest PEG Ratio

In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating and $40.00 price target on HCA Holdings (NYSE: HCA).

BofA Merrill Lynch noted, “Highlander Partners, L.P., a private investment firm, announced that Martin, Fletcher, one of its portfolio companies, has been acquired by Parallon Business Solutions, HCA's subsidiary. Martin Fletcher is a staffing company which will fit nicely into the Parallon's offering, in our view. We note that in Feb. 2011 HCA created a new subsidiary to sell its internally focused services businesses externally. While initially the external business will be relatively small, it does provide an avenue of growth that its peers lack.”

HCA Holdings closed on Tuesday at $32.98.

Latest Ratings for HCA

DateFirmActionFromTo
Sep 2014Deutsche BankMaintainsBuy
Jul 2014CitigroupMaintainsBuy
Jul 2014BarclaysMaintainsOverweight

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HCA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters